Related Experiment Video
Updated: Aug 10, 2026
11:17
Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
Published on: October 12, 2012
Heparinoids: structure, biological activities and therapeutic applications
1Division of Medicinal and Natural Products Chemistry, College of Pharmacy, University of Iowa, Iowa City, USA.
Planta Medica
|June 12, 1999
Summary
Heparin analogues, or heparinoids, are being developed to improve specificity and reduce side effects compared to traditional heparin. This review discusses their structures, activities, and therapeutic potential.
Area of Science:
- Biochemistry
- Pharmacology
- Medicinal Chemistry
Background:
- Heparin is a critical polyanionic drug with diverse biological functions.
- Research is actively pursuing enhanced heparin derivatives with improved specificity and reduced adverse effects.
- Heparin analogues, termed heparinoids, encompass a range of sulfated polysaccharides and synthetic compounds.
Purpose of the Study:
- To review the structure, biological activities, and therapeutic applications of heparinoids.
- To provide an overview of current research in heparin analogue development.
- To highlight the potential of heparinoids as therapeutic agents.
Main Methods:
- Literature review of scientific publications on heparinoids.
- Analysis of structural characteristics of various heparinoid classes.
- Synthesis and evaluation of biological activities and therapeutic potential.
Main Results:
- Heparinoids include naturally derived and synthetically modified polysaccharides.
- These analogues exhibit a spectrum of biological activities.
- Various heparinoids show promise for therapeutic applications.
Conclusions:
- Heparinoids represent a promising class of compounds for drug development.
- Further research into heparinoid structure-activity relationships is warranted.
- Heparinoids offer potential for targeted therapies with improved safety profiles.
Related Concept Videos
01:13Therapeutic Index
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
01:16Clot Retraction and Fibrinolysis
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...